CONCENTRA GROUP HOLDINGS PAR (CON) Stock Fundamental Analysis

NYSE:CON • US20603L1026

23.96 USD
+0.32 (+1.35%)
At close: Feb 27, 2026
23.96 USD
0 (0%)
After Hours: 2/27/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Overall CON gets a fundamental rating of 4 out of 10. We evaluated CON against 101 industry peers in the Health Care Providers & Services industry. CON has an excellent profitability rating, but there are concerns on its financial health. CON is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • CON had positive earnings in the past year.
  • In the past year CON had a positive cash flow from operations.
  • Of the past 5 years CON 4 years were profitable.
  • CON had a positive operating cash flow in 4 of the past 5 years.
CON Yearly Net Income VS EBIT VS OCF VS FCFCON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

  • The Return On Assets of CON (5.33%) is better than 78.22% of its industry peers.
  • CON has a better Return On Equity (39.35%) than 95.05% of its industry peers.
  • With an excellent Return On Invested Capital value of 11.29%, CON belongs to the best of the industry, outperforming 85.15% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CON is significantly above the industry average of 9.08%.
  • The last Return On Invested Capital (11.29%) for CON is well below the 3 year average (23.70%), which needs to be investigated, but indicates that CON had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.33%
ROE 39.35%
ROIC 11.29%
ROA(3y)14.38%
ROA(5y)N/A
ROE(3y)62.08%
ROE(5y)N/A
ROIC(3y)23.71%
ROIC(5y)N/A
CON Yearly ROA, ROE, ROICCON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60 80 100

1.3 Margins

  • CON's Profit Margin of 7.26% is amongst the best of the industry. CON outperforms 88.12% of its industry peers.
  • CON's Profit Margin has declined in the last couple of years.
  • With an excellent Operating Margin value of 15.61%, CON belongs to the best of the industry, outperforming 92.08% of the companies in the same industry.
  • CON's Operating Margin has declined in the last couple of years.
  • CON has a Gross Margin (28.36%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of CON has declined.
Industry RankSector Rank
OM 15.61%
PM (TTM) 7.26%
GM 28.36%
OM growth 3Y-3.12%
OM growth 5YN/A
PM growth 3Y-10.09%
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5YN/A
CON Yearly Profit, Operating, Gross MarginsCON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CON is creating value.
  • There is no outstanding debt for CON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CON Yearly Shares OutstandingCON Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
CON Yearly Total Debt VS Total AssetsCON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 1.95 indicates that CON is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CON has a Altman-Z score of 1.95. This is comparable to the rest of the industry: CON outperforms 47.52% of its industry peers.
  • CON has a debt to FCF ratio of 9.18. This is a negative value and a sign of low solvency as CON would need 9.18 years to pay back of all of its debts.
  • CON has a Debt to FCF ratio (9.18) which is in line with its industry peers.
  • CON has a Debt/Equity ratio of 4.15. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 4.15, CON is not doing good in the industry: 77.23% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.15
Debt/FCF 9.18
Altman-Z 1.95
ROIC/WACC1.4
WACC8.09%
CON Yearly LT Debt VS Equity VS FCFCON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 500M 1B

2.3 Liquidity

  • A Current Ratio of 1.20 indicates that CON should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.20, CON is in line with its industry, outperforming 43.56% of the companies in the same industry.
  • A Quick Ratio of 1.20 indicates that CON should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.20, CON perfoms like the industry average, outperforming 49.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2
CON Yearly Current Assets VS Current LiabilitesCON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15.92%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.23% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 6.93% on average over the next years.
EPS Next Y9.96%
EPS Next 2Y11.84%
EPS Next 3Y12.23%
EPS Next 5YN/A
Revenue Next Year7.53%
Revenue Next 2Y6.75%
Revenue Next 3Y6.93%
Revenue Next 5YN/A

3.3 Evolution

CON Yearly Revenue VS EstimatesCON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
CON Yearly EPS VS EstimatesCON Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.62 indicates a rather expensive valuation of CON.
  • Based on the Price/Earnings ratio, CON is valued a bit cheaper than the industry average as 76.24% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.07, CON is valued a bit cheaper.
  • CON is valuated correctly with a Price/Forward Earnings ratio of 16.02.
  • Based on the Price/Forward Earnings ratio, CON is valued a bit cheaper than 74.26% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.05. CON is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.62
Fwd PE 16.02
CON Price Earnings VS Forward Price EarningsCON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • CON's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CON is cheaper than 68.32% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CON is valued a bit cheaper than the industry average as 71.29% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.49
EV/EBITDA 11.66
CON Per share dataCON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CON has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CON's earnings are expected to grow with 12.23% in the coming years.
PEG (NY)1.77
PEG (5Y)N/A
EPS Next 2Y11.84%
EPS Next 3Y12.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.06%, CON has a reasonable but not impressive dividend return.
  • CON's Dividend Yield is rather good when compared to the industry average which is at 0.48. CON pays more dividend than 87.13% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CON's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.06%

5.2 History

  • CON is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
CON Yearly Dividends per shareCON Yearly Dividends per shareYearly Dividends per share 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

  • The earnings of CON are negative and hence is the payout ratio. CON will probably not be able to sustain this dividend level.
DP-991.33%
EPS Next 2Y11.84%
EPS Next 3Y12.23%
CON Yearly Income VS Free CF VS DividendCON Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

Find the best dividend stocksShow peers with best dividend

CONCENTRA GROUP HOLDINGS PAR

NYSE:CON (2/27/2026, 8:04:00 PM)

After market: 23.96 0 (0%)

23.96

+0.32 (+1.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)05-05
Inst Owners90.19%
Inst Owner Change-4.55%
Ins Owners8.07%
Ins Owner Change11.45%
Market Cap3.07B
Revenue(TTM)N/A
Net Income(TTM)151.68M
Analysts81.82
Price Target28.56 (19.2%)
Short Float %2.99%
Short Ratio3.54
Dividend
Industry RankSector Rank
Dividend Yield 1.06%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-991.33%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.07%
Min EPS beat(2)-2.63%
Max EPS beat(2)2.78%
EPS beat(4)3
Avg EPS beat(4)0.49%
Min EPS beat(4)-2.63%
Max EPS beat(4)2.78%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.13%
Min Revenue beat(2)0.78%
Max Revenue beat(2)1.48%
Revenue beat(4)2
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-0.78%
Max Revenue beat(4)1.48%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.52%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 17.62
Fwd PE 16.02
P/S 1.47
P/FCF 17.49
P/OCF 12.07
P/B 7.97
P/tB N/A
EV/EBITDA 11.66
EPS(TTM)1.36
EY5.68%
EPS(NY)1.5
Fwd EY6.24%
FCF(TTM)1.37
FCFY5.72%
OCF(TTM)1.99
OCFY8.28%
SpS16.3
BVpS3.01
TBVpS-10.51
PEG (NY)1.77
PEG (5Y)N/A
Graham Number9.59
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 39.35%
ROCE 12.89%
ROIC 11.29%
ROICexc 11.52%
ROICexgc 38.19%
OM 15.61%
PM (TTM) 7.26%
GM 28.36%
FCFM 8.4%
ROA(3y)14.38%
ROA(5y)N/A
ROE(3y)62.08%
ROE(5y)N/A
ROIC(3y)23.71%
ROIC(5y)N/A
ROICexc(3y)24.7%
ROICexc(5y)N/A
ROICexgc(3y)89.31%
ROICexgc(5y)N/A
ROCE(3y)27.06%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.12%
OM growth 5YN/A
PM growth 3Y-10.09%
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5YN/A
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 4.15
Debt/FCF 9.18
Debt/EBITDA 4.03
Cap/Depr 110.85%
Cap/Sales 3.77%
Interest Coverage 2.98
Cash Conversion 64.02%
Profit Quality 115.74%
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z 1.95
F-Score6
WACC8.09%
ROIC/WACC1.4
Cap/Depr(3y)84.37%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.64%
Cap/Sales(5y)N/A
Profit Quality(3y)135.77%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.71%
EPS Next Y9.96%
EPS Next 2Y11.84%
EPS Next 3Y12.23%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15.92%
Revenue Next Year7.53%
Revenue Next 2Y6.75%
Revenue Next 3Y6.93%
Revenue Next 5YN/A
EBIT growth 1Y-39%
EBIT growth 3Y-0.08%
EBIT growth 5YN/A
EBIT Next Year39.66%
EBIT Next 3Y17.62%
EBIT Next 5Y14.94%
FCF growth 1Y21.47%
FCF growth 3Y-3.19%
FCF growth 5YN/A
OCF growth 1Y17.23%
OCF growth 3Y-1.87%
OCF growth 5YN/A

CONCENTRA GROUP HOLDINGS PAR / CON FAQ

What is the fundamental rating for CON stock?

ChartMill assigns a fundamental rating of 4 / 10 to CON.


What is the valuation status of CONCENTRA GROUP HOLDINGS PAR (CON) stock?

ChartMill assigns a valuation rating of 5 / 10 to CONCENTRA GROUP HOLDINGS PAR (CON). This can be considered as Fairly Valued.


Can you provide the profitability details for CONCENTRA GROUP HOLDINGS PAR?

CONCENTRA GROUP HOLDINGS PAR (CON) has a profitability rating of 7 / 10.


How financially healthy is CONCENTRA GROUP HOLDINGS PAR?

The financial health rating of CONCENTRA GROUP HOLDINGS PAR (CON) is 3 / 10.


Can you provide the expected EPS growth for CON stock?

The Earnings per Share (EPS) of CONCENTRA GROUP HOLDINGS PAR (CON) is expected to grow by 9.96% in the next year.